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LETTER TO THE EDITORS OF HEALTH
MATRIX
IS ANTIDEPRESSANT DRUG
DISCONTINUATION WARRANTED
PRIOR TO POLYGRAPH
ADMINISTRATION?
J R. Kuykendallt
Although the use of polygraph evidence is allowed in many legal
situations, knowledge of the influence of legitimate drug use on those
tests is limited. One of the most common indications for drug therapy
is depression, and several drug classes are used to treat the many as-
pects of this psychological disorder. Currently, there are no published
guidelines or precautions for drug cessation prior to polygraph testing.
This communication is meant to address this deficiency and is in-
tended for the non-medical professional as well as the lay public.
The involuntary or "autonomic" nervous system controls basic
functions-which do not require conscious effort-such as breathing,
blood pressure, heart rate, perspiration, and body temperature. Con-
trol of these autonomic nervous functions is achieved by two opposing
systems (a sort of checks and balances effect), which are termed the
sympathetic and parasympathetic nervous systems. The sympathetic
nervous system is also termed "adrenergic" because the neurotrans-
mitters involved in these processes are the hormone epinephrine
(adrenalin) and the neurotransmitter norepinephrine. The sympathetic
nervous system is generally activated in the "flight or fight" re-
sponses, which are elicited by fear, hunger, and sexual aggression to
name a few. The chemical signals of the sympathetic nervous system
(epinephrine and norepinephrine) cause increases in blood pressure,
heart rate and breathing rate. In opposition to the sympathetic (or
excitatory) nervous system is the parasympathetic nervous system.
The parasympathetic nervous system is also termed "cholinergic"
t PhD. BioChemistry, University of Tennessee 1988; Pharm D., Idaho State
Univeristy 1994; currently Assistant Professor of Medicinal Chemistry, Raabe Col-
lege of Pharmacy, Ohio Northern University.
because the primary neurotransmitter is acetylcholine. This system is
able to cause slowing of heart rate and breathing rate. A well-
characterized exception to this scheme is the perspiration response,
which is caused by sympathetic activation, but acetylcholine is the
chemical signal that mediates this response.
The autonomic control of basal body functions such as breathing,
blood pressure, heart rate, and perspiration can be monitored using
electric and/or pneumatic devices. This is the basis of polygraph test-
ing, which employs three basic features, 1) a blood pressure cuff to
detect changes in blood pressure, 2) pneumatically operated recorders
to detect changes in respiration, and 3) electrodes fastened to the fin-
gers and connecting to an electrical device for recording of the "gal-
vanic skin reflex," which is a result of changes in the activity of sweat
pores in a person's hands.' The responses to questions are monitored
through changes in respiration, blood pressure, and perspiration,
which are not readily controlled by alterations in conscious thought
(such as motor control of voluntary movement). Rather, these altera-
tions in involuntary functions are thought to more likely represent
emotional responses to the thoughts evoked by the investigator's
questions.
The central nervous system's role in voluntary responses and con-
scious thought, among many other functions, is far more complex than
that of the involuntary peripheral nervous systems (sympathetic and
parasympathetic). However, both the central and peripheral nervous
systems use epinephrine and acetylcholine as neurotransmitters. Also,
a third major neurotransmitter, serotonin, is a primary factor involved
in the central nervous system activity. Drugs affecting behavior can
often cause changes in the norepinephrine, acetylcholine, and sero-
tonin activities in the brain. Antidepressant drugs can cause an in-
crease in either norephinephrine or serotonin (or both). Some of the
earlier antidepressants, 2 primarily affect the adrenergic (norepineph-
rine) and cholinergic (acetylcholine) systems, and some simultane-
ously affect serotonergic (serotonin) systems, as well. This could
explain the high incidence of side effects, such as changes in blood
pressure, respiration, heart rate and perspiration.
A newer class of antidepressants, known as serotonin selective re-
uptake inhibitors (SSRIs) work primarily through increases in sero-
tonin activity in the brain. These compounds, which include Prozac
(fluoxetine), are known to have minimal or no effects on adrenergic
1 The polygraph (lie-detector) technique, in SCIENTIFIC EVIDENCE IN
CRIMINAL CASES 699-723 (3rd ed. 1986).
2 Central Nervous System Agents, in DRUG FACTS AND COMPARISONS 890-
929 (Philip 0. Anderson et al. eds., 2004).
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and cholinergic systems. This results in a very different side effect
profile compared to the earlier antidepressants. As a result, the SSRIs
do not interfere with the autonomic nervous system, which controls
the involuntary nervous functions such as respiration, heart rate, blood
pressure, and perspiration.
To reiterate, drugs which affect epinephrine, norepinephrine or
acetylcholine levels could be expected to interfere with tests which
monitor the involuntary nervous system (such as those used for poly-
graph testing). However, SSRIs such as Prozac do not have this
mechanism of action; rather they work more specifically by increasing
serotonergic activity in the brain. In fact, there are no published re-
ports in the scientific medical literature (MEDLINE) to indicate that
Prozac, or any other SSRI, is able to affect polygraph results, either
positively or negatively.
Should someone request that a medication be discontinued so that
a polygraph test could be administered, the timing of the period when
the drug is withheld is important. For example, Prozac (fluoxetine)
has the longest half-life (three to four days with multiple daily dosing)
of any of the currently marketed SSRIs, 3 meaning that it will be pre-
sent in the blood stream for weeks after drug administration has
stopped. In addition, metabolites with pharmacologic activity may be
present for even longer periods of time. For instance, fluoxetine is
metabolized by the liver to norfluoxetine, which retains some of
fluoxetine's activity, yet norfluoxetine has an even longer half-life
than fluoxetine of seven to fifteen days.4 Standard procedure is to
allow seven half-lives to pass after drug discontinuation in order the
clear the drug (less than 0.01% of original drug levels remaining in
the bloodstream). This would translate to a period between 21-28
days to clear fluoxetine, and at least 49-105 days to clear its metabo-
lite. This is termed a "wash out period" and would be required in
order to eliminate any possibility that the drug may be adversely af-
fecting polygraph results by direct mechanisms. This scenario could
be applied to any medication which has pharmacological effects on
the peripheral nervous system. These may include most of the antide-
pressants, anti-anxiety, and anti-psychotic medications, as well as pain
medications, stimulants, over-the-counter cough and cold medications
and many of the commonly prescribed blood pressure and heart medi-
cations.
To further complicate the matter, many antidepressants affect the
levels of neurotransmitter receptors or the sensitivity of the receptors
3 HANDBOOK OF CLINICAL DRUG DATA 358-59 (Philip 0. Anderson et al.
eds., 1997).
4 id.
20051
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to neurotransimitter levels. This is a well-known phenomenon which
appears to be based, in part, on modulation of the receptor numbers in
nerve cells. This being the case, drug withdrawal can cause "rebound
effects" which lead to exacerbation of the very condition (such as
depression and anxiety) that antidepressants were originally intended
to treat. In many cases, discontinuation of the above medications
would not be prudent, and may even be hazardous. Conversely,
forced discontinuation of medications which do not affect polygraph
results would be unnecessary and unethical.
